BioCatalyst

Tacabrutideg — catalyst calendar

1 verified catalyst event(s) referencing Tacabrutideg, each linked to its official source. Verified as of 2026-09-20.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-11 (month)
in 1mo
ESTIMATED
 READOUT
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participant
Phase 1/2 · B-cell Malignancy, Marginal Zone Lymphoma
 ONC BeOne Medicines Ltd. Tacabrutideg ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.